Discovering Therapeutic Targets for ALS Using CRISPR-dCas9 Single-Cell Perturb-Seq in Patient-Derived Motor Neurons
Garvan Institute of Medical Research
Genomics and Cellular Biology
Project Description. Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no effective cure. Although several causal mutations (e.g. Read more
Supervisor: Dr R Weatheritt
Year round applications
PhD Research Project
Competition Funded PhD Project (Students Worldwide)